A Patients' Perspective Towards the Injection Devices for Humira® and Imraldi® in a Nationwide Switching Program

• Published in: Frontiers in Medicine
• Main Authors: Kristin Karlsdottir, Anna I. Gunnarsdottir, Gerdur Grondal, Thorvardur J. Love, Elinborg Stefansdottir, Loa G. Davidsdottir, Ragna H. Thorleifsdottir, Bjorn Gudbjornsson
• Format: Article in Journal/Newspaper
• Language: English
• Published: Frontiers Media S.A. 2022
• Subjects: adalimumab; Humira; Imraldi; injection devices; medicine administration at home; Medicine (General); R5-920; The Needle; Iceland
• Online Access: https://doi.org/10.3389/fmed.2022.799494; https://doaj.org/article/6638c416c9544571ab32334ba7fb5632

ObjectiveDue to a tender process in Iceland, all patients on Humira® were switched nationwide to its biosimilar Imraldi® in March 2019. The study aimed to explore the patient's perspective of the Humira® and Imraldi® injection devices.MethodsA standard telephone interview was carried out among...